(Q38633668)

English

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

antibiotic resistance

1 reference

based on heuristic

inferred from title

Mathias Winterhalter

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Bruno François

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Robert A Stavenger

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Stephan Harbarth

11

object named as

S Harbarth

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

T Kostyanev

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

M J M Bonten

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S O'Brien

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

H Steel

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

S Ross

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

E Tacconelli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Karlén

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Hackett

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

C Vuong

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A MacGowan

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

A Witschi

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

G Angyalosi

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

R deWinter

19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

H Goossens

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

language of work or name

0 references

publication date

15 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

290-295

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26568581%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Society's failure to protect a precious resource: antibiotics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

UK and European Union public and charitable funding from 2008 to 2013 for bacteriology and antibiotic research in the UK: an observational study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Meeting the societal need for new antibiotics: the challenges for the pharmaceutical industry

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

TRANSLOCATION project: how to get good drugs into bad bugs

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Antibiotic research and development: business as usual?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Single-dose safety, tolerability, and pharmacokinetics of the antibiotic GSK1322322, a novel peptide deformylase inhibitor

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Assessment of an anti-alpha-toxin monoclonal antibody for prevention and treatment of Staphylococcus aureus-induced pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Identification of anti-alpha toxin monoclonal antibodies that reduce the severity of Staphylococcus aureus dermonecrosis and exhibit a correlation between affinity and potency

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Staphylococcus aureus alpha toxin suppresses effective innate and adaptive immune responses in a murine dermonecrosis model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Human simulated studies of aztreonam and aztreonam-avibactam to evaluate activity against challenging gram-negative organisms, including metallo-β-lactamase producers

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

A multifunctional bispecific antibody protects against Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Activity of BAL30072 alone or combined with β-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Drug development: Time for teamwork

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

A comprehensive regulatory framework to address the unmet need for new antibacterial treatments.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKV339

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38633668&oldid=1773806817"